Literature DB >> 21051273

Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling.

Pu Xia1, Carol Wadham.   

Abstract

Sphingosine 1-phosphate (S1P) is a sphingolipid metabolite, which has emerged as an important signaling mediator participating in the regulation of multiple cellular processes. The discovery of a family of S1P receptors, together with the more recently identified intracellular targets, has provided fundamental understanding of the multi-faceted actions of S1P. Evidence from both in vitro and in vivo studies has implicated the S1P signaling system in the control of immunity, inflammation and many associated diseases. Enigmatically, S1P appears to have both pro- and anti-inflammatory effects depending on the cell context. Here, we review this emerging area and argue for a pivotal role for S1P, as a key mediator of the cytokine network, acting through juxtacrine signaling in the immune system. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051273     DOI: 10.1016/j.cytogfr.2010.09.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  21 in total

1.  Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells.

Authors:  Joanna Pyszko; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2014-01-09       Impact factor: 5.590

Review 2.  Cell-cell communication via extracellular membrane vesicles and its role in the immune response.

Authors:  Inkyu Hwang
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

3.  Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.

Authors:  H Yu; C Sun; K M Argraves
Journal:  J Periodontal Res       Date:  2015-04-20       Impact factor: 4.419

Review 4.  Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.

Authors:  Xing Liu; Qing-Hai Zhang; Guang-Hui Yi
Journal:  Mol Cell Biochem       Date:  2011-11-24       Impact factor: 3.396

Review 5.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

6.  Sphingosine kinase 2 promotes lipotoxicity in pancreatic β-cells and the progression of diabetes.

Authors:  Ziyu Song; Wei Wang; Ning Li; Sishan Yan; Kuan Rong; Tian Lan; Pu Xia
Journal:  FASEB J       Date:  2018-11-19       Impact factor: 5.191

7.  Sphingosine kinase (SphK) 1 and SphK2 play equivalent roles in mediating insulin's mitogenic action.

Authors:  Lan Dai; Yanfei Qi; Jinbiao Chen; Dominik Kaczorowski; Wen Di; Wei Wang; Pu Xia
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein Expression.

Authors:  Yanfei Qi; Wei Wang; Jinbiao Chen; Lan Dai; Dominik Kaczorowski; Xin Gao; Pu Xia
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

9.  Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.

Authors:  Ji-Sun Paik; Won-Kyung Cho; Eun-Hye Oh; Seong-Beom Lee; Suk-Woo Yang
Journal:  Mol Vis       Date:  2012-06-04       Impact factor: 2.367

10.  FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.

Authors:  Hong Yu; Bethany A Herbert; Michael Valerio; Leigh Yarborough; Li-Chien Hsu; Kelley M Argraves
Journal:  Lipids Health Dis       Date:  2015-07-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.